HCT116 cells are mutant KRAS-driven colon cancer, so compoundsthat antagonize RAF, MEK, or ERK signaling would be expected to act selectivelyagainst this tumor type21. This evidence concerns the gene MAP2K7 and malignant colon neoplasm.